EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Screening of psoriatic arthritis by dermatologists – a German nationwide survey

Andreas Pinter, Matthias Hofmann, Roland Kaufmann, Jutta Müller-Stahl, Anke König

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024

DOI: 10.1111/ddg.15486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2024. Verfasst von Andreas Pinter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology; University Hospital Frankfurt/Main, Frankfurt/Main, Germany. Hauptthemen laut MEDLINE: Arthritis, Psoriatic, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AbbVie Deutschland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Up to 30% of psoriasis (PsO) is clinically associated with psoriatic arthritis (PsA). A large proportion of new onset of PsA is diagnosed at a later stage, despite the necessity of early effective treatment to prevent structural damage. This study aimed to identify the routine screening practices used for PsA in patients with PsO. Patients and Methods This non‐interventional, prospective, epidemiological, cross‐sectional study conducted in Germany focuses on screening activity and treatment selection of dermatological practices in suspected PsA. Descriptive statistics and patient characteristics were analyzed for different center types.

Results

One hundred ninety‐five patients from 34 office‐based physicians, five non‐university hospitals, and nine university hospitals were included. Questionnaires or imaging techniques were not routinely used (< 45%). Especially, ultrasounds (≤ 5%) and MRIs (< 6.3%) were rarely performed. Between 30% and 75% of suspected PsA could be confirmed. Referral to rheumatologists and/or appropriate therapy initiation were the most frequent consequences.

Conclusions

Results of this study reflect the status of PsA screening activity by dermatologists. Imaging techniques, particularly ultrasound or MRIs to detect early forms of PsA, were inadequately used, which may have contributed to continued underdiagnoses. Collaboration between dermatologists and rheumatologists should be reviewed with a view to improving effective PsA screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticMass ScreeningHumansGermanyCross-Sectional StudiesMaleFemaleMiddle AgedPractice Patterns, Physicians'Prospective StudiesAdultDermatologistsUltrasonographyDermatologySurveys and QuestionnairesAgedReferral and ConsultationMagnetic Resonance Imaging

Stichwörter der Autor:innen

Psoriasisbiologicalscomorbiditymanagementpsoriatic arthritisscreening

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology; University Hospital Frankfurt/Main, Frankfurt/Main, Germany.
  • Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany.
  • Formerly AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.

Förderung

  • AbbVie Deutschland

Zitieren

APA

Pinter, A., Hofmann, M., Kaufmann, R., Müller-Stahl, J., & König, A. (2024). Screening of psoriatic arthritis by dermatologists – a German nationwide survey. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15486

Vancouver

Pinter A, Hofmann M, Kaufmann R, Müller-Stahl J, König A. Screening of psoriatic arthritis by dermatologists – a German nationwide survey. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024. doi:10.1111/ddg.15486

BibTeX
@article{Pinter2024,
  author = {Pinter, Andreas and Hofmann, Matthias and Kaufmann, Roland and Müller-Stahl, Jutta and König, Anke},
  title = {Screening of psoriatic arthritis by dermatologists – a German nationwide survey},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2024},
  doi = {10.1111/ddg.15486}
}
Kostenlos starten →